Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 400 shares at $505.86 ($202K) on 2025-05-02, disclosed to the SEC on 2025-05-05.
Scheduled sale ($202k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |
| VRTX | SELL | 2024-08-12 | $1.2M | — | Filing → |